Anagenics Limited (ASX:AN1)

Market Cap	3.47M
Revenue (ttm)	7.26M
Net Income (ttm)	-6.01M
Shares Out	496.32M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	93,853
Average Volume	10,865
Open	0.0080
Previous Close	0.0080
Day's Range	0.0080 - 0.0080
52-Week Range	0.0060 - 0.0170
Beta	-0.08
RSI	67.04
Earnings Date	May 28, 2025

About Anagenics

Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporat...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2004
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AN1

Financial Performance

In 2024, Anagenics's revenue was 10.80 million, an increase of 18.54% compared to the previous year's 9.11 million. Losses were -7.49 million, 180.9% more than in 2023.